These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11109977)

  • 41. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment.
    Bonde M; Qvist P; Fledelius C; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1995 Mar; 80(3):864-8. PubMed ID: 7883844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
    Warming L; Ravn P; Nielsen T; Christiansen C
    Climacteric; 2004 Mar; 7(1):103-11. PubMed ID: 15259289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
    Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M
    J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women.
    Bjarnason NH; Christiansen C
    Bone; 2000 Jun; 26(6):561-9. PubMed ID: 10831926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol.
    Ushiroyama T; Ikeda A; Sakai M; Higashiyama T; Ueki M
    Maturitas; 2003 Jun; 45(2):119-27. PubMed ID: 12787970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Effects of Hormonal Therapy and Exercise on Bone Turnover in Postmenopausal Women: A Randomised Double-Blind Pilot Study.
    Honisett SY; Tangalakis K; Wark J; Apostolopoulos V; Stojanovska L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2016 Nov; 37(2-3):23-32. PubMed ID: 27883319
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study.
    Hassager C; Colwell A; Assiri AM; Eastell R; Russell RG; Christiansen C
    Clin Endocrinol (Oxf); 1992 Jul; 37(1):45-50. PubMed ID: 1424192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of menopause and hormone replacement therapy on bone alkaline phosphatase.
    Alexandersen P; Hassager C; Riis BJ
    Scand J Clin Lab Invest; 1995 Nov; 55(7):571-6. PubMed ID: 8633181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The short-term effects of conjugated estrogen on bone turnover in older women.
    Prestwood KM; Pilbeam CC; Burleson JA; Woodiel FN; Delmas PD; Deftos LJ; Raisz LG
    J Clin Endocrinol Metab; 1994 Aug; 79(2):366-71. PubMed ID: 8045949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.
    Eastell R; Robins SP; Colwell T; Assiri AM; Riggs BL; Russell RG
    Osteoporos Int; 1993 Sep; 3(5):255-60. PubMed ID: 8400607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
    Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone sialoprotein is a specific biochemical marker of bone metabolism in postmenopausal women: a randomized 1-year study.
    Störk S; Störk C; Angerer P; Kothny W; Schmitt P; Wehr U; von Schacky C; Rambeck W
    Osteoporos Int; 2000; 11(9):790-6. PubMed ID: 11148806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
    Ravn P; Fledelius C; Rosenquist C; Overgaard K; Christiansen C
    Bone; 1996 Sep; 19(3):291-8. PubMed ID: 8873970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa.
    Grinspoon S; Baum H; Lee K; Anderson E; Herzog D; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3864-70. PubMed ID: 8923830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
    Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
    Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early effect of nasal salmon calcitonin on the bone marker Crosslaps.
    Ofluoglu D; Karadag-Saygi E; Canbulat C; Gunduz OH; Kul-Panza E; Akyuz G
    Rheumatol Int; 2006 Feb; 26(4):288-91. PubMed ID: 15875189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological effects of hormone replacement therapy in relation to serum estradiol levels.
    Yasui T; Uemura H; Tezuka M; Yamada M; Irahara M; Miura M; Aono T
    Horm Res; 2001; 56(1-2):38-44. PubMed ID: 11815726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.